[144] Proto Labs Inc SEC Filing
PRLB filed a Form 144 for a proposed sale of 9,710 common shares, with an aggregate market value of $471,629.27. The shares may be sold through Morgan Stanley Smith Barney LLC, with an approximate sale date of 11/07/2025 on the NYSE. The securities were acquired primarily via restricted stock vesting under a registered plan and an employee stock purchase plan, including tranches such as 1,567 shares vested on 02/13/2024 and 797 shares purchased on 11/15/2023.
- None.
- None.